Regular Article
Regulated Release and Polarized Localization of Brain-Derived Neurotrophic Factor in Hippocampal Neurons

https://doi.org/10.1006/mcne.1996.0017Get rights and content
Under a Creative Commons license
open archive

Abstract

The site and regulation of neurotrophic factor release from neurons is poorly understood. We used a combination of model cell lines and primary culture systems to study the polarity of BDNF sorting and the regulation of its release from hippocampal neurons. Transfection and expression of a human BDNF cDNA in a mouse pituitary cell line, AtT20, resulted in the colocalization of BDNF with the secretory granule marker, chromogranin A. Furthermore, stimulation of these cells with 56 mMKCl or with 5 mM8-bromo-cAMP increased the release of BDNF ∼10-to 15-fold within 30 min. To study BDNF release from primary cultures of hippocampal neurons, cells were infected with a defective Herpes Simplex Viral (HSV) vector expressing human BDNF. Depolarizing conditions increased the release of BDNF 5-fold from these cells, further verifying that secretion is regulated. Immunocytochemical analysis using highly specific antibodies determined that endogenous BDNF was predominantly localized to the somatodentritic domain of hippocampal neurons. These findings support the view that BDNF functions as a target-derived signal for afferents to hippocampal pyramidal cells and that it may serve as a regulator of hippocampal plasticity.

Cited by (0)

1

To whom correspondence should be addressed. Present address: Lynx Therapeutics, 3832 Bay Center Place, Hayward, CA 94545. Telephone: (510) 670-9300.